Whole-blood transcriptomics identifies a distinct metabolic and inflammatory signature in lupus arthritis compared with rheumatoid arthritis

{"BACKGROUND:":[0],"Lupus":[1],"arthritis":[2,35,55],"(LA)":[3],"is":[4],"a":[5],"major":[6],"determinant":[7],"of":[8,81,103,145,150],"clinical":[9],"outcomes":[10],"and":[11,57,68,94,105,123,148,157,163,201,204,233],"treat-to-target":[12],"strategies":[13],"in":[14,39,89,110,118,133,231,236],"systemic":[15],"lupus":[16],"erythematosus":[17],"(SLE),":[18],"yet":[19],"its":[20],"molecular":[21,183,246],"basis":[22],"remains":[23],"elusive.":[24],"METHODS:":[25],"Whole-blood":[26],"RNA":[27],"sequencing":[28],"from":[29,218],"170":[30],"SLE":[31,126],"[67":[32],"with":[33,43,161,171],"active":[34,53],"but":[36],"quiescent":[37],"disease":[38],"other":[40],"organs;":[41],"42":[42],"only":[44],"mucocutaneous":[45],"activity":[46],"(mcSLE);":[47],"61":[48],"clinically":[49],"inactive":[50],"(iSLE)],":[51],"19":[52],"rheumatoid":[54],"(RA),":[56],"72":[58],"healthy":[59],"donors.":[60],"Pathway":[61],"enrichment,":[62],"unsupervised":[63],"WGCNA,":[64],"deconvolution,":[65],"k-means":[66],"clustering,":[67],"druggability":[69],"analyses":[70],"were":[71,86,115,130,159,178],"applied.":[72],"RESULTS:":[73],"Compared":[74],"to":[75,121,139,143,241],"mcSLE,":[76],"LA":[77,93,119,138,176,232,244],"patients":[78,177],"demonstrated":[79],"upregulation":[80,102,144],"ribosome/metabolism,":[82],"while":[83],"inflammatory":[84,194,205],"pathways":[85,109,129,188,195,206],"significantly":[87,116],"upregulated":[88,132],"mcSLE.":[90,124],"Comparison":[91],"between":[92],"RA":[95,122,167],"revealed":[96,214],"769":[97],"differentially":[98],"expressed":[99],"genes,":[100],"indicating":[101],"ribosome/metabolism":[104],"oxidative":[106],"phosphorylation":[107],"(OXPHOS)":[108],"LA.":[111,134],"Activated":[112],"NK":[113],"cells":[114],"increased":[117],"compared":[120],"Within":[125],"patients,":[127],"interferon":[128],"less":[131],"Unsupervised":[135],"analysis":[136,213],"showed":[137],"be":[140],"strongly":[141,169],"linked":[142],"\\"OXPHOS/metabolism\\"":[146],"module":[147],"downregulation":[149],"the":[151,172],"\\"Interferon\\"":[152,162],"module.":[153,175],"In":[154],"contrast,":[155],"mcSLE":[156],"iSLE":[158],"associated":[160,170],"\\"T-cell\\"":[164],"modules,":[165],"respectively.":[166],"was":[168],"\\"Innate":[173],"immunity\\"":[174],"categorized":[179],"into":[180],"three":[181],"distinct":[182,250],"clusters":[184],"dominated":[185],"by":[186,249,255],"OXPHOS/metabolism":[187],"(\\"metabolism\\"":[189],"cluster;":[190,197,208],"n":[191,198,209],"=":[192,199,210],"14),":[193],"(\\"inflammation\\"":[196],"29),":[200],"both":[202],"metabolic":[203],"(\\"mixed\\"":[207],"24).":[211],"Druggability":[212],"differential":[215],"anticipated":[216],"benefit":[217],"different":[219],"compounds":[220],"for":[221,238],"each":[222],"LA-cluster.":[223],"CONCLUSIONS:":[224],"Metabolic":[225],"-rather":[226],"than":[227],"inflammatory-pathways":[228],"are":[229],"dominant":[230],"may":[234],"account":[235],"part":[237],"suboptimal":[239],"responses":[240],"existing":[242],"therapies.":[243],"encompasses":[245],"subtypes,":[247],"characterized":[248],"pathophysiologic":[251],"aberrancies":[252],"potentially":[253],"reversible":[254],"unique":[256],"compounds.":[257]}